Acrivon Therapeutics, Inc. (ACRV) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $17.20M | -13.1% |
| 2024 | $19.80M | +16.0% |
| 2023 | $17.07M | +58.8% |
| 2022 | $10.75M | +36.5% |
| 2021 | $7.88M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $17.20M | -13.1% |
| 2024 | $19.80M | +16.0% |
| 2023 | $17.07M | +58.8% |
| 2022 | $10.75M | +36.5% |
| 2021 | $7.88M | — |